The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
D000328:Adult; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004357:Drug Synergism; D005260:Female; D006065:Gonadotropins, Pituitary / Q000652:urine*; D006801:Humans; D007986:Luteinizing Hormone / Q000502:physiology / Q000652:urine*; D008535:Megestrol / Q000494:pharmacology; D008598:Menstruation; D008656:Mestranol / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects*; D010902:Pituitary Gland / Q000187:drug effects / Q000502:physiology; D011276:Pregnanediol / Q000652:urine; D011372:Progestins / Q000494:pharmacology*
D003276:Contraceptives, Oral; D006065:Gonadotropins, Pituitary; D011372:Progestins; D007986:Luteinizing Hormone; D008656:Mestranol; D008535:Megestrol; D011276:Pregnanediol